Agomelatine Prevents Relapse in Generalized Anxiety Disorder

Dan Joseph Stein; Antti Ahokas; Cristina Albarran; Valérie Olivier; Christer Allgulander

doi:10.4088/jcp.11m07493

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2014

Agomelatine in Generalized Anxiety Disorder

Dan Joseph Stein, Antti Ahokas, Miguel Márquez, Cyril Höschl, Kang‐Seob Oh, Marek Jarema, А С Аведисова, Cristina Albarran, Valérie Olivier

Article2008

Efficacy of Agomelatine in Generalized Anxiety Disorder

Dan Joseph Stein, Antti Ahokas, Christian de Bodinat

Article2011

Long-term treatment with agomelatine: prevention of relapse in patients with generalised anxiety disorder over 6 months

Dan Joseph Stein, Antti Ahokas, Christer Allgulander, J. Soegaard, István Bitter, Andres Lehtmets, Kurt Wahlstedt, Michael Van Amerigen

Article2017

Efficacy and safety of agomelatine 25-50 mg/day versus escitalopram 10-20 mg/day in severe generalized anxiety disorder

Dan Joseph Stein, Jon‐Paul Khoo, D.M. Van Ameringen, Cyril Höschl, Antti Ahokas, Max Bauer, István Bitter, Marek Jarema, S.N. Mosolov, L. Vavrušová, F. Picarel-Blanchot, Sophie Matharan, Valérie Olivier

Article2021

Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine

Dan Joseph Stein